Pressmeddelanden, rapporter och bolagsmeddelande för ODI Pharma
Spotlight News
Nyhetsuppdatering från ODI Pharma
Reports: ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma AB receives loan financing of EUR 350,000
Spotlight News
Nyhetsuppdatering från ODI Pharma
Reports: ODI Pharma AB: Publication of interim report report Q3 2022/2023
Spotlight News
Nyhetsuppdatering från ODI Pharma
Reports: ODI Pharma AB: Publication of half-year report 2022/2023
Spotlight News
Nyhetsuppdatering från ODI Pharma
Reports: ODI Pharma AB: Publication of half-year report 2022/2023
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharma receives approval from the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland to distribute and sell its products on the Polish market
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Announcement from the Annual General Meeting in ODI Pharma AB (publ)
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Kommuniké från årsstämma i ODI Pharma AB (publ)